Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study

BACKGROUND: Vedolizumab has become a standard treatment for the inflammatory bowel diseases ulcerative colitis (UC) and Crohn’s disease (CD). However, there is an ongoing debate on the ideal individual treatment algorithms and means to predict treatment response are not routinely established. AIMS:...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Gastroenterol
Main Authors: Mühl, Laura, Becker, Emily, Müller, Tanja M., Atreya, Raja, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821503/
https://ncbi.nlm.nih.gov/pubmed/33482730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-021-01604-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki